AuraVax Therapeutics Inc., a biotech company based in Houston, is developing a COVID-19 nasal spray vaccine. AuraVax has entered a license option agreement with the University of Houston, which will give them the option to exclusively license the nasal spray vaccine technology that was developed by M.D. Anderson Professor of […]